{
    "info": {
        "nct_id": "NCT05440786",
        "official_title": "A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination With Irinotecan and Temozolomide in Participants With Relapsed or Refractory Ewing's Sarcoma",
        "inclusion_criteria": "* Diagnosis of Ewing's sarcoma or Ewing's sarcoma-like tumor by institutional pathologist. The original pathological report is required. Repeat biopsy at progression is not required\n* Refractory disease or confirmed radiological progression or recurrence following first or later line of treatment of Ewing's sarcoma or Ewing's sarcoma-like tumor\n\n  -- Must have one measurable or evaluable lesion per RECIST 1.1\n* Adequate performance status based on age\n\n  * For participants less than (<)16 years of age, a Lansky score greater than or equal to (≥)50, or\n  * For participants ≥16 years of age, a Karnofsky score ≥50\n* Participants must have discontinued all previous treatments for cancer or investigational agents ≥7 days after the last dose and must have recovered from the acute effects\n* Adequate hematologic and organ function less than or equal to (≤)14 days prior to Day 1 of Cycle 1:\n\n  * Absolute neutrophil count ≥1000/microliter (µL)\n  * Platelets ≥75,000/cubic millimeter (mm³)\n  * Hemoglobin ≥8 grams per deciLiter (g/Dl) (≥100 grams per Liter [g/L])\n  * Total bilirubin ≤1.5 times (×) upper limit of normal (ULN)\n  * Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤3 × ULN\n  * Creatinine clearance or calculated glomerular filtration rate (GFR) ≥60 milliliters per minute per square meter (Ml/min/m²) or serum creatinine based on age/gender\n* Female participants of childbearing potential must have a negative urine or serum pregnancy test\n* Body weight ≥10 kilograms (kg)\n* Must be able to swallow and/or have a gastric/nasogastric tube\n\n  -- Participants in the European Union must be able to swallow intact capsules\n* Stable or decreasing dose of steroids at least 7 days prior to enrollment\n* Life expectancy of at least 8 weeks and able to complete at least 1 cycle of treatment\n* Participants/caregivers are able and willing to make themselves available for the duration of the study and are willing to follow study procedures, including adherence to the pharmacokinetic (PK) sampling schedule\nHealthy volunteers allowed\nMust have minimum age of 1 Year\nMust have maximum age of 39 Years",
        "exclusion_criteria": "* Participants with severe and/or uncontrolled concurrent medical disease or psychiatric illness/social situation that in the opinion of the investigator could cause unacceptable safety risks or compromise compliance with the protocol\n* Participants with an active fungal, bacterial, and/or known severe viral infection including, but not limited to, human immunodeficiency virus (HIV) or viral (A, B, or C) hepatitis.\n* Participants who have had allogeneic bone marrow or solid organ transplant\n* Surgery: Participants who have had, or are planning to have, the following invasive procedures:\n\n  * Major surgical procedure, laparoscopic procedure, or significant traumatic injury within 28 days prior to enrollment\n  * Surgical or other wounds must be adequately healed prior to enrollment\n* Female participants who are pregnant or breastfeeding\n* Have received any prior cyclin-dependent kinase (CDK) 4 and 6 inhibitor\n* Progression during prior treatment with irinotecan and/or temozolomide\n* Have a known intolerability or hypersensitivity to any of the study treatments or dacarbazine\n* Diagnosed and/or treated additional malignancy within 3 years prior to enrollment",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤3 × ULN",
            "criterions": [
                {
                    "exact_snippets": "Aspartate aminotransferase (AST) ... ≤3 × ULN",
                    "criterion": "aspartate aminotransferase (AST) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "alanine aminotransferase (ALT) ≤3 × ULN",
                    "criterion": "alanine aminotransferase (ALT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate hematologic and organ function less than or equal to (≤)14 days prior to Day 1 of Cycle 1:",
            "criterions": [
                {
                    "exact_snippets": "Adequate hematologic and organ function less than or equal to (≤)14 days prior to Day 1 of Cycle 1",
                    "criterion": "hematologic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days prior to Day 1 of Cycle 1"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate hematologic and organ function less than or equal to (≤)14 days prior to Day 1 of Cycle 1",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days prior to Day 1 of Cycle 1"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "-- Participants in the European Union must be able to swallow intact capsules",
            "criterions": [
                {
                    "exact_snippets": "Participants in the European Union must be able to swallow intact capsules",
                    "criterion": "ability to swallow intact capsules",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Body weight ≥10 kilograms (kg)",
            "criterions": [
                {
                    "exact_snippets": "Body weight ≥10 kilograms (kg)",
                    "criterion": "body weight",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "kg"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Refractory disease or confirmed radiological progression or recurrence following first or later line of treatment of Ewing's sarcoma or Ewing's sarcoma-like tumor",
            "criterions": [
                {
                    "exact_snippets": "Refractory disease",
                    "criterion": "disease status",
                    "requirements": [
                        {
                            "requirement_type": "refractory",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "confirmed radiological progression",
                    "criterion": "disease status",
                    "requirements": [
                        {
                            "requirement_type": "radiological progression",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "recurrence following first or later line of treatment",
                    "criterion": "disease status",
                    "requirements": [
                        {
                            "requirement_type": "recurrence after treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Ewing's sarcoma or Ewing's sarcoma-like tumor",
                    "criterion": "diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "disease type",
                            "expected_value": [
                                "Ewing's sarcoma",
                                "Ewing's sarcoma-like tumor"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 1 Year",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 1 Year",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "Year"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelets ≥75,000/cubic millimeter (mm³)",
            "criterions": [
                {
                    "exact_snippets": "Platelets ≥75,000/cubic millimeter (mm³)",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 75000,
                                "unit": "cubic millimeter (mm³)"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate performance status based on age",
            "criterions": [
                {
                    "exact_snippets": "Adequate performance status based on age",
                    "criterion": "performance status",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "age-adjusted",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants must have discontinued all previous treatments for cancer or investigational agents ≥7 days after the last dose and must have recovered from the acute effects",
            "criterions": [
                {
                    "exact_snippets": "must have discontinued all previous treatments for cancer or investigational agents ≥7 days after the last dose",
                    "criterion": "previous cancer treatments or investigational agents",
                    "requirements": [
                        {
                            "requirement_type": "discontinuation duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "must have recovered from the acute effects",
                    "criterion": "acute effects of previous treatments",
                    "requirements": [
                        {
                            "requirement_type": "recovery",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female participants of childbearing potential must have a negative urine or serum pregnancy test",
            "criterions": [
                {
                    "exact_snippets": "Female participants of childbearing potential",
                    "criterion": "sex and childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must have a negative urine or serum pregnancy test",
                    "criterion": "pregnancy test result",
                    "requirements": [
                        {
                            "requirement_type": "test type",
                            "expected_value": [
                                "urine",
                                "serum"
                            ]
                        },
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants/caregivers are able and willing to make themselves available for the duration of the study and are willing to follow study procedures, including adherence to the pharmacokinetic (PK) sampling schedule",
            "criterions": [
                {
                    "exact_snippets": "Participants/caregivers are able ... to make themselves available for the duration of the study",
                    "criterion": "availability for study duration",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Participants/caregivers are ... willing to make themselves available for the duration of the study",
                    "criterion": "willingness to participate for study duration",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willing to follow study procedures",
                    "criterion": "willingness to follow study procedures",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including adherence to the pharmacokinetic (PK) sampling schedule",
                    "criterion": "adherence to PK sampling schedule",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute neutrophil count ≥1000/microliter (µL)",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count ≥1000/microliter (µL)",
                    "criterion": "absolute neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "microliter (µL)"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of Ewing's sarcoma or Ewing's sarcoma-like tumor by institutional pathologist. The original pathological report is required. Repeat biopsy at progression is not required",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of Ewing's sarcoma or Ewing's sarcoma-like tumor by institutional pathologist",
                    "criterion": "diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "disease type",
                            "expected_value": [
                                "Ewing's sarcoma",
                                "Ewing's sarcoma-like tumor"
                            ]
                        },
                        {
                            "requirement_type": "confirmation by",
                            "expected_value": "institutional pathologist"
                        }
                    ]
                },
                {
                    "exact_snippets": "The original pathological report is required",
                    "criterion": "original pathological report",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For participants less than (<)16 years of age, a Lansky score greater than or equal to (≥)50, or",
            "criterions": [
                {
                    "exact_snippets": "participants less than (<)16 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<",
                                "value": 16,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Lansky score greater than or equal to (≥)50",
                    "criterion": "Lansky score",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 39 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 39 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 39,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For participants ≥16 years of age, a Karnofsky score ≥50",
            "criterions": [
                {
                    "exact_snippets": "participants ≥16 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 16,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Karnofsky score ≥50",
                    "criterion": "Karnofsky score",
                    "requirements": [
                        {
                            "requirement_type": "minimum score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy of at least 8 weeks and able to complete at least 1 cycle of treatment",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy of at least 8 weeks",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "able to complete at least 1 cycle of treatment",
                    "criterion": "ability to complete treatment cycle",
                    "requirements": [
                        {
                            "requirement_type": "minimum cycles",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "cycle"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must be able to swallow and/or have a gastric/nasogastric tube",
            "criterions": [
                {
                    "exact_snippets": "Must be able to swallow",
                    "criterion": "swallowing ability",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "have a gastric/nasogastric tube",
                    "criterion": "gastric or nasogastric tube",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin ≥8 grams per deciLiter (g/Dl) (≥100 grams per Liter [g/L])",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin ≥8 grams per deciLiter (g/Dl) (≥100 grams per Liter [g/L])",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 8,
                                        "unit": "g/dL"
                                    },
                                    {
                                        "operator": ">=",
                                        "value": 100,
                                        "unit": "g/L"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "-- Must have one measurable or evaluable lesion per RECIST 1.1",
            "criterions": [
                {
                    "exact_snippets": "Must have one measurable or evaluable lesion per RECIST 1.1",
                    "criterion": "lesion",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "N/A"
                            }
                        },
                        {
                            "requirement_type": "measurability or evaluability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment criteria",
                            "expected_value": "RECIST 1.1"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Creatinine clearance or calculated glomerular filtration rate (GFR) ≥60 milliliters per minute per square meter (Ml/min/m²) or serum creatinine based on age/gender",
            "criterions": [
                {
                    "exact_snippets": "Creatinine clearance ... ≥60 milliliters per minute per square meter (Ml/min/m²)",
                    "criterion": "creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "ml/min/m²"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "calculated glomerular filtration rate (GFR) ≥60 milliliters per minute per square meter (Ml/min/m²)",
                    "criterion": "glomerular filtration rate (GFR)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "ml/min/m²"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "serum creatinine based on age/gender",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": "based on age/gender"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin ≤1.5 times (×) upper limit of normal (ULN)",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin ≤1.5 times (×) upper limit of normal (ULN)",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "times ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stable or decreasing dose of steroids at least 7 days prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Stable or decreasing dose of steroids at least 7 days prior to enrollment",
                    "criterion": "steroid dose",
                    "requirements": [
                        {
                            "requirement_type": "trend",
                            "expected_value": [
                                "stable",
                                "decreasing"
                            ]
                        },
                        {
                            "requirement_type": "duration_prior_to_enrollment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Have a known intolerability or hypersensitivity to any of the study treatments or dacarbazine",
            "criterions": [
                {
                    "exact_snippets": "known intolerability ... any of the study treatments",
                    "criterion": "intolerability to study treatments",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hypersensitivity to any of the study treatments",
                    "criterion": "hypersensitivity to study treatments",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "intolerability ... dacarbazine",
                    "criterion": "intolerability to dacarbazine",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hypersensitivity to ... dacarbazine",
                    "criterion": "hypersensitivity to dacarbazine",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Surgical or other wounds must be adequately healed prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Surgical or other wounds must be adequately healed prior to enrollment",
                    "criterion": "surgical or other wounds",
                    "requirements": [
                        {
                            "requirement_type": "healing status",
                            "expected_value": "adequately healed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female participants who are pregnant or breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "Female participants who are pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "pregnant"
                        }
                    ]
                },
                {
                    "exact_snippets": "Female participants who are ... breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "breastfeeding"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Major surgical procedure, laparoscopic procedure, or significant traumatic injury within 28 days prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Major surgical procedure ... within 28 days prior to enrollment",
                    "criterion": "major surgical procedure",
                    "requirements": [
                        {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "laparoscopic procedure ... within 28 days prior to enrollment",
                    "criterion": "laparoscopic procedure",
                    "requirements": [
                        {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "significant traumatic injury within 28 days prior to enrollment",
                    "criterion": "significant traumatic injury",
                    "requirements": [
                        {
                            "requirement_type": "time since injury",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Surgery: Participants who have had, or are planning to have, the following invasive procedures:",
            "criterions": [
                {
                    "exact_snippets": "Participants who have had, or are planning to have, the following invasive procedures",
                    "criterion": "invasive surgical procedures",
                    "requirements": [
                        {
                            "requirement_type": "history or plan",
                            "expected_value": [
                                "have had",
                                "are planning to have"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants who have had allogeneic bone marrow or solid organ transplant",
            "criterions": [
                {
                    "exact_snippets": "Participants who have had allogeneic bone marrow ... transplant",
                    "criterion": "allogeneic bone marrow transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Participants who have had ... solid organ transplant",
                    "criterion": "solid organ transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Progression during prior treatment with irinotecan and/or temozolomide",
            "criterions": [
                {
                    "exact_snippets": "Progression during prior treatment with irinotecan",
                    "criterion": "disease progression during prior irinotecan treatment",
                    "requirements": [
                        {
                            "requirement_type": "history of progression during treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Progression during prior treatment with ... temozolomide",
                    "criterion": "disease progression during prior temozolomide treatment",
                    "requirements": [
                        {
                            "requirement_type": "history of progression during treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosed and/or treated additional malignancy within 3 years prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Diagnosed ... additional malignancy within 3 years prior to enrollment",
                    "criterion": "additional malignancy",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "time reference",
                            "expected_value": "prior to enrollment"
                        }
                    ]
                },
                {
                    "exact_snippets": "treated additional malignancy within 3 years prior to enrollment",
                    "criterion": "additional malignancy",
                    "requirements": [
                        {
                            "requirement_type": "treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "time reference",
                            "expected_value": "prior to enrollment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have received any prior cyclin-dependent kinase (CDK) 4 and 6 inhibitor",
            "criterions": [
                {
                    "exact_snippets": "Have received any prior cyclin-dependent kinase (CDK) 4 and 6 inhibitor",
                    "criterion": "prior CDK4/6 inhibitor therapy",
                    "requirements": [
                        {
                            "requirement_type": "history of receipt",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with severe and/or uncontrolled concurrent medical disease or psychiatric illness/social situation that in the opinion of the investigator could cause unacceptable safety risks or compromise compliance with the protocol",
            "criterions": [
                {
                    "exact_snippets": "severe and/or uncontrolled concurrent medical disease",
                    "criterion": "concurrent medical disease",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness/social situation that in the opinion of the investigator could cause unacceptable safety risks or compromise compliance with the protocol",
                    "criterion": "psychiatric illness or social situation",
                    "requirements": [
                        {
                            "requirement_type": "investigator judgment of risk",
                            "expected_value": "could cause unacceptable safety risks or compromise compliance with the protocol"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with an active fungal, bacterial, and/or known severe viral infection including, but not limited to, human immunodeficiency virus (HIV) or viral (A, B, or C) hepatitis.",
            "criterions": [
                {
                    "exact_snippets": "active fungal, bacterial, and/or known severe viral infection",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "infection_type",
                            "expected_value": [
                                "fungal",
                                "bacterial",
                                "severe viral"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "including, but not limited to, human immunodeficiency virus (HIV) or viral (A, B, or C) hepatitis",
                    "criterion": "specific viral infections",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "infection_type",
                            "expected_value": [
                                "HIV",
                                "hepatitis A",
                                "hepatitis B",
                                "hepatitis C"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}